Lupin launches generic version of Brovana in US

It is indicated for the long-term, twice-daily maintenance treatment of bronchoconstriction in patients with COPD

Lupin announced the launch of the authorised generic version of Brovana (arformoterol tartrate) Inhalation Solution 15 mcgꝉ/2 mL, unit-dose vials, of Sunovion Pharmaceuticals.

Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL, is indicated for the long-term, twice daily (morning and evening) maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is for use by nebulisation only.

arformoterol tartrateBrovanachronic bronchitisCOPDemphysemaLupinSunovion Pharmaceuticals
Comments (1)
Add Comment